Altravax's Grant

Altravax raised a round of funding on October 14, 2010. Investors include National Institute of Allergy and Infectious Diseases.

Altravax is a biopharmaceutical company that has acquired the rights to MolecularBreeding directed molecular evolution technology in the area of infectious diseases. The company is focused on the disc…

Articles about Altravax's Grant: